MedTrace Logo

Cryotherapy in Treating Patients With Lung Cancer That Has Spread to the Other Lung or Parts of the Body

NCT01325753 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2018-07-03

No results posted yet for this study

Summary

This pilot clinical trial studies the side effects of cryotherapy (cryoablation \[CA\]) in treating patients with lung cancer. Cryotherapy kills cancer cells by freezing them.

Conditions

  • Advanced Malignant Mesothelioma
  • Extensive Stage Small Cell Lung Cancer
  • Lung Metastases
  • Recurrent Malignant Mesothelioma
  • Recurrent Non-small Cell Lung Cancer
  • Recurrent Small Cell Lung Cancer
  • Stage IV Non-small Cell Lung Cancer

Interventions

PROCEDURE

cryotherapy

Undergo CT-guided CA

PROCEDURE

quality-of-life assessment

Ancillary studies

Sponsors & Collaborators

  • Wake Forest University Health Sciences

    lead OTHER

Principal Investigators

  • James Urbanic · Wake Forest University Health Sciences

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2013-03-31
Completion
2017-03-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01325753 on ClinicalTrials.gov